TET1 and B-cell chronic lymphocytic leukemia: By performing pyrosequencing on additional 40 CLL samples and 5 normal healthy age-matched sorted B cell samples, we further validated methylation status of the TET1 gene-body and its promoter regions (20 IGHV mutated + 20 IGHV unmutated samples) (Figure 1B).